These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22674790)

  • 1. The MIA-QSAR method for the prediction of bioactivities of possible acetylcholinesterase inhibitors.
    Bitencourt M; Freitas MP; Rittner R
    Arch Pharm (Weinheim); 2012 Sep; 345(9):723-8. PubMed ID: 22674790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combinatorial feature selection approach to describe the QSAR of dual site inhibitors of acetylcholinesterase.
    Asadabadi EB; Abdolmaleki P; Barkooie SM; Jahandideh S; Rezaei MA
    Comput Biol Med; 2009 Dec; 39(12):1089-95. PubMed ID: 19854437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D-QSAR analysis of a new type of acetylcholinesterase inhibitors.
    Liu A; Guang H; Zhu L; Du G; Lee SM; Wang Y
    Sci China C Life Sci; 2007 Dec; 50(6):726-30. PubMed ID: 17914643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MIA-QSAR based model for bioactivity prediction of flavonoid derivatives as acetylcholinesterase inhibitors.
    Muthukumaran P; Rajiniraja M
    J Theor Biol; 2018 Dec; 459():103-110. PubMed ID: 30267791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-dependent (RD) 3D-QSAR approach of a series of benzylpiperidine inhibitors of human acetylcholinesterase (HuAChE).
    Araújo JQ; de Brito MA; Hoelz LV; de Alencastro RB; Castro HC; Rodrigues CR; Albuquerque MG
    Eur J Med Chem; 2011 Jan; 46(1):39-51. PubMed ID: 21074294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D QSAR studies of AChE inhibitors based on molecular docking scores and CoMFA.
    Akula N; Lecanu L; Greeson J; Papadopoulos V
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6277-80. PubMed ID: 17049234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of the pharmacophore model of acetylcholinesterase inhibitor.
    Zhu Y; Tong XY; Zhao Y; Chen H; Jiang FC
    Yao Xue Xue Bao; 2008 Mar; 43(3):267-76. PubMed ID: 18630262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of acetylcholinesterase inhibitors and characterization of correlative molecular descriptors by machine learning methods.
    Lv W; Xue Y
    Eur J Med Chem; 2010 Mar; 45(3):1167-72. PubMed ID: 20053484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introducing new dimensions in MIA-QSAR: a case for chemokine receptor inhibitors.
    Nunes CA; Freitas MP
    Eur J Med Chem; 2013 Apr; 62():297-300. PubMed ID: 23357311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular docking and 3D-QSAR studies of 2-substituted 1-indanone derivatives as acetylcholinesterase inhibitors.
    Shen LL; Liu GX; Tang Y
    Acta Pharmacol Sin; 2007 Dec; 28(12):2053-63. PubMed ID: 18031622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation of structurally diverse carbamates for acetylcholinesterase (AChE) inhibition using 3D-QSAR analysis.
    Roy KK; Dixit A; Saxena AK
    J Mol Graph Model; 2008 Sep; 27(2):197-208. PubMed ID: 18515163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.
    Mizutani MY; Itai A
    J Med Chem; 2004 Sep; 47(20):4818-28. PubMed ID: 15369385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIA-QSAR evaluation of a series of sulfonylurea herbicides.
    Bitencourt M; Freitas MP
    Pest Manag Sci; 2008 Aug; 64(8):800-7. PubMed ID: 18338340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anchor-GRIND: filling the gap between standard 3D QSAR and the GRid-INdependent descriptors.
    Fontaine F; Pastor M; Zamora I; Sanz F
    J Med Chem; 2005 Apr; 48(7):2687-94. PubMed ID: 15801859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-based 3D-QSAR studies of physostigmine analogues as acetylcholinesterase inhibitors.
    Ul-Haq Z; Mahmood U; Jehangir B
    Chem Biol Drug Des; 2009 Dec; 74(6):571-81. PubMed ID: 19843075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, evaluation and QSAR analysis of N(1)-substituted norcymserine derivatives as selective butyrylcholinesterase inhibitors.
    Takahashi J; Hijikuro I; Kihara T; Murugesh MG; Fuse S; Kunimoto R; Tsumura Y; Akaike A; Niidome T; Okuno Y; Takahashi T; Sugimoto H
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1718-20. PubMed ID: 20137934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monte Carlo QSAR models for predicting organophosphate inhibition of acetycholinesterase.
    Veselinović JB; Nikolić GM; Trutić NV; Živković JV; Veselinović AM
    SAR QSAR Environ Res; 2015 Jun; 26(6):449-60. PubMed ID: 26043064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and acetylcholinesterase inhibitory activity of novel coumarin analogues.
    Zhou X; Wang XB; Wang T; Kong LY
    Bioorg Med Chem; 2008 Sep; 16(17):8011-21. PubMed ID: 18701305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative structure and bioactivity relationship study on human acetylcholinesterase inhibitors.
    Yan A; Wang K
    Bioorg Med Chem Lett; 2012 May; 22(9):3336-42. PubMed ID: 22460031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative structure-activity relationships for organophosphates binding to acetylcholinesterase.
    Ruark CD; Hack CE; Robinson PJ; Anderson PE; Gearhart JM
    Arch Toxicol; 2013 Feb; 87(2):281-9. PubMed ID: 22990135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.